Association of pyrazinamide resistance in Mycobacterium tuberculosis with mutations in rpoB, katG, and inhA genes

Abstract Multidrug-resistant tuberculosis (MDR-TB) is associated with a high rate of treatment failure. Since the 9 to 11-month shorter oral regimen in MDR-TB treatment includes pyrazinamide (PZA), it is essential to assess the susceptibility of MDR-TB strains to PZA to guide effective therapy. The...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Kartiki Srivastava, Salman Khan, Rajniti Prasad, Sada Nand Pandey, Shampa Anupurba
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Nature Portfolio 2026-05-01
Edice:	Scientific Reports
Témata:	Mycobacterium tuberculosis Multidrug resistance Line probe assay Rifampicin Isoniazid Pyrazinamide
On-line přístup:	https://doi.org/10.1038/s41598-026-53296-8
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!